This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (44)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Arie Markel, MD; Richard A. Manzo, CCVT; D. Eugene Strandness, Jr, MD

Arch Intern Med. 1992;152(6):1265-1267.

Abstract
Background.—
Anticoagulant therapy for lower extremity deep-vein thrombosis (DVT) has been shown to reduce mortality from pulmonary embolism, but subsequent morbidity from the postthrombotic syndrome remains high. Thrombolytic therapy produces higher lysis rates of venous thrombi than heparin alone. Some studies suggest a lower incidence of postthrombotic sequelae after early use of streptokinase. These potential benefits are limited to those patients without contraindications for this therapy.

Methods.—
For the past 3 years we have prospectively studied patients with DVT documented by duplex scanning. The records of these patients were reviewed to determine what proportion of this population would have been candidates for thrombolytic therapy. For this analysis, contraindications to the use of thrombolytic agents included: (1) recent surgery (<1 month); (2) recent major trauma; (3) active or recent bleeding; (4) brain disease (cerebrovascular accident, brain tumor, arteriovenous malformation); (5) pregnancy; and (6) bleeding diathesis. Also, patients with prior ipsilateral DVT and those with acute symptoms present for 7 or more days were not considered to be candidates for thrombolytic therapy.

Results.—
A contraindication to thrombolytic therapy was present in 194 (93%) of 209 patients with a diagnosis of DVT, including four patients with a relative contraindication. Two or more contraindications were present in 65 cases (31%). Recent surgery was the most frequent factor precluding therapy, being present in 71 patients. A history of DVT in the affected leg was present in 45 patients.

Conclusions.—
Only 15 (7%) of 209 patients with DVT exhibited no contraindications for thrombolytic treatment. Only a small fraction of patients with venous thrombosis will be potential candidates for this therapy.

(Arch Intern Med. 1992;152:1265-1267)

Author Affiliations
From the Department of Surgery, University of Washington School of Medicine, Seattle.

Footnotes
Accepted for publication December 27, 1991.

Reprint requests to the Division of Vascular Surgery, Department of Surgery, RF-25, University of Washington, 1959 NE Pacific St, Seattle, WA 98195 (Dr Strandness).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Endovascular treatment of septic thrombophlebitis: a case report of a rare complication and review of the literature
Schifferdecker et al.
Vasc Med 2009;14:47-50.
ABSTRACT  

Thrombolytic Therapy for Deep Venous Thrombosis?
Horne III and Chang
JAMA 1999;282:2164-2166.
ABSTRACT | FULL TEXT  

Percutaneous venous interventions
Bravo et al.
Vasc Med 1998;3:61-66.
ABSTRACT  

Management of Venous Thromboembolism
Ginsberg
NEJM 1996;335:1816-1829.
FULL TEXT  

Is Thrombolysis of Venous Thrombosis an Option in Treatment?
Cairols
VASC ENDOVASCULAR SURG 1996;30:451-452.
 

Thrombolytic Therapy for Venous Thromboembolism: Utilization by Practicing Pulmonologists
Witty et al.
Arch Intern Med 1994;154:1601-1604.
ABSTRACT  

Recent Developments in the Diagnosis, Treatment, and Prevention of Pulmonary Embolism
Hastings et al.
Arch Fam Med 1993;2:655-669.
ABSTRACT